Back to search

Spain· ES:8685206

FUCIBET 20 MG/G + 1 MG/G CREMA

A medicinal product containing betametasona + ácido fusídico, registered in Spain by Leo Pharma A/S.

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedFUCIBET 20 MG/G + 1 MG/G CREMAATC—REGISTER NO.ES:8685206PACKS LISTED0CHECKEDJune 3, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
betametasona + ácido fusídico
Manufacturer
Leo Pharma A/S
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
June 3, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Betametasona + ácido fusídico in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All betametasona + ácido fusídico products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Fucibet Lipid, Fusicutan
  • Belgium · Atosene, Defucort
  • Bulgaria · Бетафузин, Фусибет Липид
  • Cyprus · Betacort, Betafusin
  • Czechia · Fucicort, Imaxema
  • Germany · Betagalen Plus Fusidinsäure, Fucicort®
  • Denmark · Fucicort, Fucicort Lipid
  • Estonia · Fucicort
  • Finland · Addicort, Fucicort
  • France · Dermafusone
  • United Kingdom (Northern Ireland) · Fucibet, Fusidic Acid & Betamethasone Generics [uk]
  • Greece · Alpider, Bet-Fu
  • Hungary · Fucicort, Metafuzin
  • Ireland · Fucibet, Fucibet®
  • Italy · Fucicort, Fucimixbeta
  • Lithuania · Enosat, Fucicort
  • Luxembourg · Atosene, Defucort
  • Latvia · Enosat, Fucicort
  • Malta · Cortofusin, Fucibet®
  • Norway · Addicort
  • Poland · Dermisil, Fucibet Lipid
  • Portugal · Betametasona + Ácido Fusídico Mylan, Fucicort
  • Romania · Fucicort, Imaxema
  • Sweden · Addicort
  • Slovakia · Fucicort, Imaxema

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d215338c-d53e-463c-965a-d6c998e656d9
GET /v1/drugs/d215338c-d53e-463c-965a-d6c998e656d9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":1778071390000}",
  "nregistro": "8685206",
  "substance": "betametasona + ácido fusídico"
}

See everything about betametasona + ácido fusídico.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.